Replies to post #134254 on Biotech Values

[JJM760]

I am going out on a limb here and predicting Loc gets the thumbs up.

My reason for this bold prediction? I liquidated my entire position @ $1.50 last year. RATS!!!! (no pun intended)

[Superfly15]

Whether this makes ARNA a compelling buy at an enterprise value of roughly $300M is unclear. My cursory answer is no, but I’d be somewhat more inclined to take a flier after today’s news than I would have been previously, even after accounting for the double-digit price gain in the AH session.

I think ARNA is a great trading vehicle, but as long as Jack Lief is running the ship I will never again invest another dollar of my money in this one. I hope the FDA tells them to shut up and actually run the 12 month rat study like they asked for.